This antibody binds to SLAMF7 on myeloma cells, simultaneously activating NK cells and macrophages through the SLAMF7-EAT2 interaction and stimulating the FYN/Syk-PI3K-Akt/mTOR signaling pathway. Here, SYK is linked to plasma cell myeloma.